Review the side-effects of Miglustat as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The authorisation covers combination use with miglustat, or as a single therapy if miglustat cannot be tolerated.

Discover comprehensive details about Miglustat, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Credit: Getty Images. AT-GAA consists of cipaglucosidase alfa administered in conjunction with miglustat. The Food and Drug Administration has accepted for review the Biologics License Application for ...

Purpose: To evaluate the safety and efficacy of miglustat in patients with G M2 gangliosidosis. Methods: A randomized, multicenter, open-label, 12-month study involving patients aged 18 years or older ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Agents that prevent glycolipid biosynthesis have been shown to be beneficial in individuals with lysosomal storage diseases such as Niemann–Pick type C disease (NPC). In a recent study, Patterson et ...

The drug miglustat appears to stabilize the swallowing problems that occur in children and adolescents with Niemann-Pick type C1 (NPC1), a rare and ultimately fatal neurological disease, according to ...

Miglustat is a drug currently under phase 2 clinical trials on patients suffering from cystic fibrosis. Its potential for treating the disease was discovered in 2006 and researchers can now show that ...

2.1 Cipaglucosidase alfa (Pombiliti, Amicus Therapeutics Ltd) is indicated as 'a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of ...